当前位置： SCI文献检索 > Genome Medicine期刊下所有文献 > Huntington's disease: the case for genetic modifiers.

Huntington's disease: the case for genetic modifiers.

Abstract：

:For almost three decades, Huntington's disease has been a prototype for the application of genetic strategies to human disease. HD, the Huntington's disease gene, was the first autosomal defect mapped using only DNA markers, a finding in 1983 that helped to spur similar studies in many other disorders and contributed to the concept of the human genome project. The search for the genetic defect itself pioneered many mapping and gene-finding technologies, and culminated in the identification of the HD gene, its mutation and its novel protein product in 1993. Since that time, extensive investigations into the pathogenic mechanism have utilized the knowledge of the disease gene and its defect but, with notable exceptions, have rarely relied for guidance on the genetic findings in human patients to interpret the relevance of findings in non-human model systems. However, the human patient still has much to teach us through a detailed analysis of genotype and phenotype. Such studies have implicated the existence of genetic modifiers - genes whose natural polymorphic variation contributes to altering the development of Huntington's disease symptoms. The search for these modifiers, much as the search for the HD gene did in the past, offers to open new entrées into the process of Huntington's disease pathogenesis by unlocking the biochemical changes that occur many years before diagnosis, and thereby providing validated target proteins and pathways for development of rational therapeutic interventions.

journal_name

Genome Med

journal_title

Genome medicine

authors

Gusella JF,MacDonald ME

doi

10.1186/gm80

subject

Has Abstract

pub_date

2009-08-21 00:00:00

pages

80

issue

8

issn

1756-994X

pii

gm80

journal_volume

1

pub_type

杂志文章

相关文献

Genome Medicine文献大全
  • Stem cell banking: between traceability and identifiability.

    abstract：:Stem cell banks are increasingly seen as an essential resource of biological materials for both basic and translational research. Stem cell banks support transnational access to quality-controlled and ethically sourced stem cell lines from different origins and of varying grades. According to the Organisation for Econ...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm194

    authors： Knoppers BM,Isasi R

    更新日期：2010-10-05 00:00:00

  • DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma.

    abstract：BACKGROUND:Organic cation transporters (OCTs) determine not only physiological processes but are also involved in the cellular uptake of anticancer agents. Based on microarray analyses in hepatocellular carcinoma (HCC), SLC22A1/OCT1 mRNA seems to be downregulated, but systematic protein expression data are currently mi...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm298

    authors： Schaeffeler E,Hellerbrand C,Nies AT,Winter S,Kruck S,Hofmann U,van der Kuip H,Zanger UM,Koepsell H,Schwab M

    更新日期：2011-12-23 00:00:00

  • Optimizing the treatment of BRAF mutant melanoma.

    abstract：:Selective inhibitors of the kinases BRAF and MEK for the treatment of patients with otherwise refractory BRAF mutant melanoma have demonstrated impressive efficacy, and combination treatment with these agents may prove to be even more effective. However, these drugs are not curative, mainly because of the relatively r...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm547

    authors： Settleman J

    更新日期：2014-04-28 00:00:00

  • CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling.

    abstract：:CRISPR/Cas9 has revolutionized cancer mouse models. Although loss-of-function genetics by CRISPR/Cas9 is well-established, generating gain-of-function alleles in somatic cancer models is still challenging because of the low efficiency of gene knock-in. Here we developed CRISPR-based Somatic Oncogene kNock-In for Cance...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-019-0627-9

    authors： Mou H,Ozata DM,Smith JL,Sheel A,Kwan SY,Hough S,Kucukural A,Kennedy Z,Cao Y,Xue W

    更新日期：2019-04-16 00:00:00

  • Environment-driven somatic mosaicism in brain disorders.

    abstract：:The identification of somatic mosaicism in the brain lends a new perspective to our understanding of the role of gene and environment interactions in psychiatric disease risk. Somatic mutations, such as retrotransposon insertions, that are precipitated by modern environmental factors may alter neuronal function and ne...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-016-0317-9

    authors： Bedrosian TA,Linker S,Gage FH

    更新日期：2016-05-23 00:00:00

  • Network strategies to understand the aging process and help age-related drug design.

    abstract：:Recent studies have demonstrated that network approaches are highly appropriate tools for understanding the extreme complexity of the aging process. Moreover, the generality of the network concept helps to define and study the aging of technological and social networks and ecosystems, which may generate novel concepts...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm90

    authors： Simkó GI,Gyurkó D,Veres DV,Nánási T,Csermely P

    更新日期：2009-09-28 00:00:00

  • De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome.

    abstract：BACKGROUND:Molecular diagnostics can resolve locus heterogeneity underlying clinical phenotypes that may otherwise be co-assigned as a specific syndrome based on shared clinical features, and can associate phenotypically diverse diseases to a single locus through allelic affinity. Here we describe an apparently novel s...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm415

    authors： Bainbridge MN,Hu H,Muzny DM,Musante L,Lupski JR,Graham BH,Chen W,Gripp KW,Jenny K,Wienker TF,Yang Y,Sutton VR,Gibbs RA,Ropers HH

    更新日期：2013-02-05 00:00:00

  • Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression.

    abstract：BACKGROUND:Myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) are characterised by abnormal epigenetic repression and differentiation of bone marrow haematopoietic stem cells (HSCs). Drugs that reverse epigenetic repression, such as 5-azacytidine (5-AZA), induce haematological improvement in half of trea...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-019-0707-x

    authors： Kazachenka A,Young GR,Attig J,Kordella C,Lamprianidou E,Zoulia E,Vrachiolias G,Papoutselis M,Bernard E,Papaemmanuil E,Kotsianidis I,Kassiotis G

    更新日期：2019-12-23 00:00:00

  • Progress in the use of RNA interference as a therapy for chronic hepatitis B virus infection.

    abstract：:Chronic infection with hepatitis B virus (HBV) occurs in approximately 6% of the world's population and carriers of the virus are at risk for hepatocellular carcinoma and cirrhosis. Current treatment regimens, which include interferon-alpha and nucleoside/nucleotide analogs, are only partially effective and new treatm...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm149

    authors： Weinberg MS,Arbuthnot P

    更新日期：2010-04-28 00:00:00

  • Hematopoietic stem cells, hematopoiesis and disease: lessons from the zebrafish model.

    abstract：:The zebrafish model is rapidly gaining prominence in the study of development, hematopoiesis, and disease. The zebrafish provides distinct advantages over other vertebrate models during early embryonic development by producing transparent, externally fertilized embryos. Embryonic zebrafish are easily visualized and ma...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm299

    authors： Martin CS,Moriyama A,Zon LI

    更新日期：2011-12-29 00:00:00

  • Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

    abstract：BACKGROUND:Chemotherapeutic agents such as anthracyclines and taxanes are commonly used in the neoadjuvant setting. Bevacizumab is an antibody which binds to vascular endothelial growth factor A (VEGFA) and inhibits its receptor interaction, thus obstructing the formation of new blood vessels. METHODS:A phase II rando...

    journal_title：Genome medicine

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1186/s13073-018-0601-y

    authors： Höglander EK,Nord S,Wedge DC,Lingjærde OC,Silwal-Pandit L,Gythfeldt HV,Vollan HKM,Fleischer T,Krohn M,Schlitchting E,Borgen E,Garred Ø,Holmen MM,Wist E,Naume B,Van Loo P,Børresen-Dale AL,Engebraaten O,Kristensen V

    更新日期：2018-11-29 00:00:00

  • Personalizing carbamazepine therapy.

    abstract：:The anticonvulsant carbamazepine has a high incidence of cutaneous adverse drug reactions. A recent prospective clinical trial in Taiwan has indicated that HLA-B*1502 screening will reduce the incidence of life-threatening adverse reactions to carbamazepine, while a genome-wide association study has identified the HLA...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm243

    authors： Mushiroda T,Nakamura Y

    更新日期：2011-05-30 00:00:00

  • Allele-specific expression in the human heart and its application to postoperative atrial fibrillation and myocardial ischemia.

    abstract：BACKGROUND:Allele-specific expression (ASE) is differential expression of each of the two chromosomal alleles of an autosomal gene. We assessed ASE patterns in the human left atrium (LA, n = 62) and paired samples from the left ventricle (LV, n = 76) before and after ischemia, and tested the utility of differential ASE...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-016-0381-1

    authors： Sigurdsson MI,Saddic L,Heydarpour M,Chang TW,Shekar P,Aranki S,Couper GS,Shernan SK,Seidman JG,Body SC,Muehlschlegel JD

    更新日期：2016-12-06 00:00:00

  • Functional profiling of the gut microbiome in disease-associated inflammation.

    abstract：:The microbial residents of the human gut are a major factor in the development and lifelong maintenance of health. The gut microbiota differs to a large degree from person to person and has an important influence on health and disease due to its interaction with the human immune system. Its overall composition and mic...

    journal_title：Genome medicine

    pub_type： 杂志文章,评审

    doi：10.1186/gm469

    authors： Börnigen D,Morgan XC,Franzosa EA,Ren B,Xavier RJ,Garrett WS,Huttenhower C

    更新日期：2013-07-31 00:00:00

  • Enabling multiplexed testing of pooled donor cells through whole-genome sequencing.

    abstract：:We describe a method that enables the multiplex screening of a pool of many different donor cell lines. Our method accurately predicts each donor proportion from the pool without requiring the use of unique DNA barcodes as markers of donor identity. Instead, we take advantage of common single nucleotide polymorphisms,...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-018-0541-6

    authors： Chan Y,Chan YK,Goodman DB,Guo X,Chavez A,Lim ET,Church GM

    更新日期：2018-04-19 00:00:00

  • A population-based gene expression signature of molecular clock phase from a single epidermal sample.

    abstract：BACKGROUND:For circadian medicine to influence health, such as when to take a drug or undergo a procedure, a biomarker of molecular clock phase is required--one that is easily measured and generalizable across a broad population. It is not clear that any circadian biomarker yet satisfies these criteria. METHODS:We ana...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-020-00768-9

    authors： Wu G,Ruben MD,Francey LJ,Smith DF,Sherrill JD,Oblong JE,Mills KJ,Hogenesch JB

    更新日期：2020-08-21 00:00:00

  • Best practices for bioinformatic characterization of neoantigens for clinical utility.

    abstract：:Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tumor-specific T cell recognition. Recently, researchers and clinicians have leveraged next generation sequencing technologies to identify neoantigens and to create personalized immunotherapies for cancer treatment. To cr...

    journal_title：Genome medicine

    pub_type： 杂志文章,评审

    doi：10.1186/s13073-019-0666-2

    authors： Richters MM,Xia H,Campbell KM,Gillanders WE,Griffith OL,Griffith M

    更新日期：2019-08-28 00:00:00

  • NARD: whole-genome reference panel of 1779 Northeast Asians improves imputation accuracy of rare and low-frequency variants.

    abstract：:Here, we present the Northeast Asian Reference Database (NARD), including whole-genome sequencing data of 1779 individuals from Korea, Mongolia, Japan, China, and Hong Kong. NARD provides the genetic diversity of Korean (n = 850) and Mongolian (n = 384) ancestries that were not present in the 1000 Genomes Project Phas...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-019-0677-z

    authors： Yoo SK,Kim CU,Kim HL,Kim S,Shin JY,Kim N,Yang JSW,Lo KW,Cho B,Matsuda F,Schuster SC,Kim C,Kim JI,Seo JS

    更新日期：2019-10-22 00:00:00

  • Creating a data resource: what will it take to build a medical information commons?

    abstract：:National and international public-private partnerships, consortia, and government initiatives are underway to collect and share genomic, personal, and healthcare data on a massive scale. Ideally, these efforts will contribute to the creation of a medical information commons (MIC), a comprehensive data resource that is...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-017-0476-3

    authors： Deverka PA,Majumder MA,Villanueva AG,Anderson M,Bakker AC,Bardill J,Boerwinkle E,Bubela T,Evans BJ,Garrison NA,Gibbs RA,Gentleman R,Glazer D,Goldstein MM,Greely H,Harris C,Knoppers BM,Koenig BA,Kohane IS,La Rosa S,

    更新日期：2017-09-22 00:00:00

  • Mining the literature: new methods to exploit keyword profiles.

    abstract：UNLABELLED:Bibliographic records in the PubMed database of biomedical literature are annotated with Medical Subject Headings (MeSH) by curators, which summarize the content of the articles. Two recent publications explain how to generate profiles of MeSH terms for a set of bibliographic records and to use them to defin...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm382

    authors： Andrade-Navarro MA

    更新日期：2012-10-30 00:00:00

  • Genome-wide association studies are coming for human infectious diseases.

    abstract：:A genetic contribution to infectious disease in human populations has long been suspected and is now supported by more than 50 years of epidemiological evidence showing, for example, infection rates to be much higher than disease rates. In successful family studies of high-penetrance effects, single gene mutations hav...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm19

    authors： Davila S,Hibberd ML

    更新日期：2009-02-10 00:00:00

  • A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition.

    abstract：BACKGROUND:Antibiotic-resistant Klebsiella pneumoniae are a major cause of hospital- and community-acquired infections, including sepsis, liver abscess, and pneumonia, driven mainly by the emergence of successful high-risk clonal lineages. The K. pneumoniae sequence type (ST) 307 lineage has appeared in several differe...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-020-00814-6

    authors： Heiden SE,Hübner NO,Bohnert JA,Heidecke CD,Kramer A,Balau V,Gierer W,Schaefer S,Eckmanns T,Gatermann S,Eger E,Guenther S,Becker K,Schaufler K

    更新日期：2020-12-09 00:00:00

  • Genetic relatedness analysis reveals the cotransmission of genetically related Plasmodium falciparum parasites in Thiès, Senegal.

    abstract：BACKGROUND:As public health interventions drive parasite populations to elimination, genetic epidemiology models that incorporate population genomics can be powerful tools for evaluating the effectiveness of continued intervention. However, current genetic epidemiology models may not accurately simulate the population ...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-017-0398-0

    authors： Wong W,Griggs AD,Daniels RF,Schaffner SF,Ndiaye D,Bei AK,Deme AB,MacInnis B,Volkman SK,Hartl DL,Neafsey DE,Wirth DF

    更新日期：2017-01-24 00:00:00

  • Genome-wide approaches for identifying genetic risk factors for osteoporosis.

    abstract：:Osteoporosis, the most common type of bone disease worldwide, is clinically characterized by low bone mineral density (BMD) and increased susceptibility to fracture. Multiple genetic and environmental factors and gene-environment interactions have been implicated in its pathogenesis. Osteoporosis has strong genetic de...

    journal_title：Genome medicine

    pub_type： 杂志文章,评审

    doi：10.1186/gm448

    authors： Wu S,Liu Y,Zhang L,Han Y,Lin Y,Deng HW

    更新日期：2013-05-29 00:00:00

  • Actionable gene-based classification toward precision medicine in gastric cancer.

    abstract：BACKGROUND:Intertumoral heterogeneity represents a significant hurdle to identifying optimized targeted therapies in gastric cancer (GC). To realize precision medicine for GC patients, an actionable gene alteration-based molecular classification that directly associates GCs with targeted therapies is needed. METHODS:A...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-017-0484-3

    authors： Ichikawa H,Nagahashi M,Shimada Y,Hanyu T,Ishikawa T,Kameyama H,Kobayashi T,Sakata J,Yabusaki H,Nakagawa S,Sato N,Hirata Y,Kitagawa Y,Tanahashi T,Yoshida K,Nakanishi R,Oki E,Vuzman D,Lyle S,Takabe K,Ling Y,Okuda

    更新日期：2017-10-31 00:00:00

  • Predictive, preventive, personalized and participatory medicine: back to the future.

    abstract：:The pioneering work of Jean Dausset on the HLA system established several principles that were later reflected in the Human Genome Project and contributed to the foundations of predictive, preventive, personalized and participatory (P4) medicine. To effectively develop systems medicine, we should take advantage of the...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm178

    authors： Auffray C,Charron D,Hood L

    更新日期：2010-08-26 00:00:00

  • DNA methylation signature in blood mirrors successful weight-loss during lifestyle interventions: the CENTRAL trial.

    abstract：BACKGROUND:One of the major challenges in obesity treatment is to explain the high variability in the individual's response to specific dietary and physical activity interventions. With this study, we tested the hypothesis that specific DNA methylation changes reflect individual responsiveness to lifestyle intervention...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-020-00794-7

    authors： Keller M,Yaskolka Meir A,Bernhart SH,Gepner Y,Shelef I,Schwarzfuchs D,Tsaban G,Zelicha H,Hopp L,Müller L,Rohde K,Böttcher Y,Stadler PF,Stumvoll M,Blüher M,Kovacs P,Shai I

    更新日期：2020-11-16 00:00:00

  • Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles.

    abstract：BACKGROUND:The apolipoprotein E (APOE) ε4 allele is the strongest genetic risk factor for late onset Alzheimer's disease, whilst the ε2 allele confers protection. Previous studies report differential DNA methylation of APOE between ε4 and ε2 carriers, but associations with epigenome-wide methylation have not previously...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-020-00808-4

    authors： Walker RM,Vaher K,Bermingham ML,Morris SW,Bretherick AD,Zeng Y,Rawlik K,Amador C,Campbell A,Haley CS,Hayward C,Porteous DJ,McIntosh AM,Marioni RE,Evans KL

    更新日期：2021-01-04 00:00:00

  • The pan-cancer landscape of prognostic germline variants in 10,582 patients.

    abstract：BACKGROUND:While clinical factors such as age, grade, stage, and histological subtype provide physicians with information about patient prognosis, genomic data can further improve these predictions. Previous studies have shown that germline variants in known cancer driver genes are predictive of patient outcome, but no...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/s13073-020-0718-7

    authors： Chatrath A,Przanowska R,Kiran S,Su Z,Saha S,Wilson B,Tsunematsu T,Ahn JH,Lee KY,Paulsen T,Sobierajska E,Kiran M,Tang X,Li T,Kumar P,Ratan A,Dutta A

    更新日期：2020-02-17 00:00:00

  • Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.

    abstract：BACKGROUND:The advent of personalized medicine requires robust, reproducible biomarkers that indicate which treatment will maximize therapeutic benefit while minimizing side effects and costs. Numerous molecular signatures have been developed over the past decade to fill this need, but their validation and up-take into...

    journal_title：Genome medicine

    pub_type： 杂志文章

    doi：10.1186/gm385

    authors： Starmans MH,Pintilie M,John T,Der SD,Shepherd FA,Jurisica I,Lambin P,Tsao MS,Boutros PC

    更新日期：2012-11-12 00:00:00